How Do You Translate Limited and Inconclusive Evidence Into Coverage Policies?

Share Article

Hayes, Inc. experts demonstrate how to apply information to create defensible coverage policies.

Reviewing the medical need for genetic tests and writing coverage policies for these complex assays and conditions can be a daunting task. Creating defensible coverage policies becomes more challenging when the evidence is limited and inconclusive. Translating Limited and Inconclusive Evidence about Genetic Tests into Coverage Policy, a webinar hosted by Hayes, Inc. will demonstrate how to translate Hayes’ conclusions and recommendations about the evidence into coverage policy. Reserve your seat now to attend this complimentary, 1-hour live webinar on Wednesday, July 16, 2014 at 12:30 pm ET.

“Payers are being challenged to develop evidence-based coverage policies for the thousands of genetic and genomic tests that patients are asking for and physicians are prescribing,” says Dr. Diane Allingham-Hawkins, PhD, FCCMG, FACMG, Senior Director of the Hayes Genetic Test Evaluation Program. “Regrettably, many of these tests have been rushed to the market without sufficient evidence of their clinical utility. When evidence is limited or inconclusive, it can be difficult to create a defensible coverage policy.”

During this webinar, Dr. Allingham-Hawkins and Pamela Weber, Director of Client Services, will guide participants through a hypothetical example to illustrate how to take the conclusions and recommendations found in the Hayes genetic testing reports to design coverage policies for their organizations. Translating Limited and Inconclusive Evidence about Genetic Tests into Coverage Policy is designed for anyone involved in coverage policy development and determination. This includes medical directors, health plan care managers, and claims specialists.

About Hayes
Hayes, Inc., an internationally recognized leader in health technology research and consulting, is dedicated to the delivery of high-quality healthcare and improved outcomes through the integration of evidence into decision making and policy development. The unbiased information and comparative-effectiveness analyses we provide enable evidence-based decisions about acquiring, managing, and paying for health technologies. Our worldwide clients include hospitals, healthcare systems, government agencies, health plans, and employers. Hayes, Inc. is a certified woman-owned small business (WOSB).

For more information about Hayes, Inc., visit Or, contact Hayes, Inc. by mail at 157 S. Broad Street, Lansdale, PA 19446; by telephone at 215.855.0615; by email hayesinfo(at)hayesinc(dot)com; or by fax at 215.855.5218.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Matthias
Visit website